Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Ранг среди акций #39281
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Цена акции
$2.06
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$572.30K
Изменение (1 день)
0.00%
Изменение (1 год)
-90.38%
Страна
CA
Торговля XORTX Therapeutics Inc. (XRTX)

Категория

История цены акций XORTX Therapeutics Inc. (XRTX)
Наивысшая цена закрытия: $2.06 2026-08-01

Наименьшая цена закрытия: $173.60 2015-10-01
История цены акций XORTX Therapeutics Inc. с 2015 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$517.18 32.51%
US
$857.76 31.47%
NL
$731.95 7.17%
CH
$1.07K -6.40%
KR
$257.04 13.55%
BE